EPoSS - The Product Driven Platform

Scientific Conference on Biomarkers for Brain Disorders: Challenges and Opportunities

— filed under:

The event will take place in Cambridge, 3-6 February 2013.

What
  • Conference
When 03 February 2013 08:00 AM to
06 February 2013 05:00 PM
Where Cambridge, UK
Add event to calendar vCal
iCal

The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics.

The conference will be an opportunity for researchers and stakeholders to discuss the current latest in biomarkers and the standardisation of clinical biomarkers most likely to aid in the diagnosis and imaging-based studies in biomarker drug discovery.

This conference will  bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs.

Biomarkers 2013

Topics

  • Methodological and regulatory aspects of biomarker identification and qualification across a wide spectrum of neurodevelopmental, neurodegenerative and neuropsychiatric diseases will be discussed including, autism, Parkinson's disease, Alzheimer’s disease, multiple sclerosis and schizophrenia.
  • There will also be a series of break-out sessions for in-depth discussion on the standardization of clinical biomarkers most likely to aid diagnosis and imaging-based studies in biomarker drug discovery.

Scientific Organizers

Giovanni Frisoni IRCCS Fatebenefratelli, Brescia, Italy
Andreas Jeromin Banyan Biomarkers, USA
Andy Lockhart GlaxoSmithKline, UK
William Potter formerly Merck, Inc., USA

Further information on this Wellcome Trust Scientific Conference, and a list of invited speakers, will be available soon.

To be kept updated, please contact at scientificconferences@hinxton.wellcome.ac.uk.

More information about this event…

Document Actions





  • EPoSS © 2005 – 2017